1
|
Ruiz F, Jehng T, Spindler T, Munson D, Karlen J, Thota V, Wang A, Chuan J, Yedwabnick M, Dubovsky J, Aftab BT. COMPREHENSIVE ACTIVATION PROFILING OF TABELECLEUCEL, AN OFF‐THE‐SHELF, ALLOGENEIC EBV‐SPECIFIC T‐CELL IMMUNOTHERAPY. Hematol Oncol 2021. [DOI: 10.1002/hon.90_2881] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- F. Ruiz
- Atara Biotherapeutics Thousand Oaks California USA
| | - T. Jehng
- Atara Biotherapeutics Thousand Oaks California USA
| | - T. Spindler
- Atara Biotherapeutics Thousand Oaks California USA
| | - D. Munson
- Atara Biotherapeutics Thousand Oaks California USA
| | - J. Karlen
- Atara Biotherapeutics Thousand Oaks California USA
| | - V. Thota
- Atara Biotherapeutics Thousand Oaks California USA
| | - A. Wang
- Atara Biotherapeutics Thousand Oaks California USA
| | - J. Chuan
- Atara Biotherapeutics Thousand Oaks California USA
| | | | - J. Dubovsky
- Atara Biotherapeutics Thousand Oaks California USA
| | - B. T. Aftab
- Atara Biotherapeutics Thousand Oaks California USA
| |
Collapse
|
2
|
Ruiz F, Jehng T, Spindler T, Munson D, Karlen J, Thota V, Wang A, Chuan J, Yedwabnick M, Dubovksy J, Aftab B. Comprehensive activation profiling of tabelecleucel, an off-the-shelf, allogeneic EBV-specific T-cell immunotherapy. Cytotherapy 2021. [DOI: 10.1016/s146532492100548x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|